MS in Patent Law, The University of Notre Dame du Lac, May 2015 (expected) BS in Chemistry, Creighton University, May 2002; PhD in Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, December 2009.
Lynn Roy has experience in both industrial and academic research. In graduate school, he worked in the field of reproductive endocrinology. His dissertation examined cross-talk between cAMP/PKA and GSK3 b / b -catenin signaling in corpus luteum progesterone synthesis. After obtaining his PhD, Lynn continued his research career at Novartis Pharma in Basel, Switzerland where he changed his focus and worked in the bone group researching potential treatments for osteoporosis. Upon return to the U.S., Lynn joined the laboratories of Dr. Karen Cowden Dahl and Dr. Richard Dahl at the Indiana University School of Medicine-South Bend as a postdoctoral fellow. There he worked on two different projects. He studied the regulation of blood development by a particular microRNA, miR24. He also examined the role of ARID3B in ovarian cancer progression, metastasis, and relapse.
While Lynn thoroughly enjoyed working at the lab bench, he is currently attending the University of Notre Dame’s Master of Science in Patent Law program. He hopes to utilize his scientific training and expertise to help his fellow scientists protect their inventions. The journey from basic laboratory research to the clinic is long and arduous. It can take several years or even decades to get a medical device or drug ready for public use and many bench scientists never get to see this happen with their work. The investment of time, money, and ingenuity by these scientists deserves to be protected. Lynn hopes to join a company in the biomedical industry as a patent agent.
While earning his MS in Patent Law, Lynn is working in Notre Dame’s Intellectual Property and Entrepreneurship Clinic.
Lynn can be reached at email@example.com